← ANALYST RATINGS · TIPRANKS

Centene (CNC): analyst forecast and price target

$69.16 −1.91% close 16.10.26 · market cap $34.8B · Healthcare · Medical - Healthcare Plans SPY 0.05%
Price targets and ratings of

Analyst consensus

Moderate Buy

4 Buy5 Hold0 Sell

Ratings of 9 analysts in the last 3 months · top analysts only

12-month forecast

$73.75+6.6% upside

Based on 9 price targets given in the last 3 months, the average target is $73.75, the highest $80.00, the lowest $66.00. The average is +6.6% from the last price of $69.16.

$40.00$60.00$80.00Jan 26AprJulOctJan 27AprJulOctHigh$80.00Average$73.75Low$66.00
Highest target $80.00 Average target $73.75 Lowest target $66.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% RBC Capital $71.00 Hold +2.7% Reiterated 07.10.26on TipRanks Oct 8 21:45 +0.8%next day −0.3% · 5 days +8.9%
Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% Bernstein $79.00 Buy +14.2% Reiterated 05.10.26on TipRanks 07:30 +1.4%next day −0.1% · 5 days +3.8%
Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% Bank of America Securities $80.00 Buy +15.7% Reiterated 24.09.26on TipRanks 05:15 −0.2%next day −0.7% · 5 days −1.1%
Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% Barclays $80.00 Buy +15.7% Reiterated 17.09.26on TipRanks 04:35 +0.5%next day −3.1% · 5 days −8.6%
Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% Wells Fargo $69.00 Hold −0.2% Reiterated 15.09.26on TipRanks 07:20 −2.1%next day −2.0% · 5 days −8.8%
Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% Bernstein $79.00 Buy +14.2% Reiterated 09.09.26on TipRanks 06:35 −0.3%next day +2.7% · 5 days +4.1%
John Stansel★★★★★★★★★★#9374 · hits 46% · avg −2.3% J.P. Morgan $67.00 Hold −3.1% Assigned 20.08.26on TipRanks 07:50 0.0%next day +1.0% · 5 days +0.7%
John Staszak★★★★★★★★★★#835 · hits 59% · avg +8.8% Argus Research $80.00 Buy +15.7% Upgrade 10.08.26on TipRanks Aug 11 08:35 +1.2%next day −2.2% · 5 days −3.2%
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $65.00 Hold −6.0% Assigned 30.07.26on TipRanks Jul 29 03:10 −1.7%next day −3.3% · 5 days +2.8%
Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% Morgan Stanley $57.00 → $66.00+15.8% Hold −4.6% Reiterated 29.07.26on TipRanks 08:17 −1.7%next day −3.3% · 5 days +2.8%
A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% UBS $61.00 → $70.00+14.8% Hold +1.2% Reiterated 29.07.26on TipRanks 08:08 −1.7%next day −3.3% · 5 days +2.8%
David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% Truist Financial $78.00 → $80.00+2.6% Buy +15.7% Reiterated 29.07.26on TipRanks 07:48 −1.7%next day −3.3% · 5 days +2.8%
Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% Robert W. Baird $46.00 → $66.00+43.5% Hold −4.6% Reiterated 29.07.26on TipRanks 06:51 −1.7%next day −3.3% · 5 days +2.8%
Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% Cantor Fitzgerald $75.00 Buy +8.4% Reiterated 28.07.26on TipRanks Jul 29 08:50 −0.5%next day −1.7% · 5 days −3.9%
Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% RBC Capital $71.00 Hold +2.7% Reiterated 28.07.26on TipRanks Jul 29 07:41 −0.5%next day −1.7% · 5 days −3.9%
Jason Cassorla★★★★★★★★★★#3435 · hits 57% · avg +5.7% Guggenheim — Hold — Reiterated 28.07.26on TipRanks Jul 29 07:41 −0.5%next day −1.7% · 5 days −3.9%
Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% Mizuho Securities $63.00 → $69.00+9.5% Hold −0.2% Reiterated 13.07.26on TipRanks 08:15 +2.2%next day +0.3% · 5 days −2.6%
George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% Deutsche Bank $80.00 Buy +15.7% Upgrade 20.05.26on TipRanks 21:20 −1.1%next day +2.0% · 5 days +1.3%
Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% Oppenheimer $45.00 → $58.00+28.9% Buy −16.1% Assigned 29.04.26on TipRanks 08:00 +8.9%next day −1.5% · 5 days −0.6%
Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% Goldman Sachs $32.00 → $40.00+25.0% Sell −42.2% Reiterated 29.04.26on TipRanks 07:30 +8.9%next day −1.5% · 5 days −0.6%
David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% Jefferies $39.00 Hold −43.6% Reiterated 20.04.26on TipRanks 05:40 +0.6%next day +2.8% · 5 days +12.6%
Unknown Analyst Roth MKM $43.00 → $45.00+4.7% Buy −34.9% Reiterated 30.10.25on TipRanks 08:20 −5.1%next day +0.7% · 5 days +7.3%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Centene

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Lance Wilkes★★★★★★★★★★Bernstein · #1628
Hits 63%82 of 130 Average return +11.3%
1 year Kevin Fischbeck★★★★★★★★★★Bank of America Securities · #8009
Hits 57%201 of 351 Average return +0.1%
2 years Lance Wilkes★★★★★★★★★★Bernstein · #1628
Hits 63%82 of 130 Average return +11.3%

Most profitable

3 months Lance Wilkes★★★★★★★★★★Bernstein · #1628
Hits 63%82 of 130 Average return +11.3%
1 year Lance Wilkes★★★★★★★★★★Bernstein · #1628
Hits 63%82 of 130 Average return +11.3%
2 years Lance Wilkes★★★★★★★★★★Bernstein · #1628
Hits 63%82 of 130 Average return +11.3%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $72.64 at a price of $62.12 (+16.9%); now: $72.92 at $69.16 (+5.4%).

$65.00$70.00Sep 15Oct 1Oct 15Top analysts$73.75Average target$72.92Price$69.16

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

010209142Oct 2510112Nov6102Dec77Jan 261011Feb110121Mar19123Apr1793May9112Jun814Jul1011Aug108Sep72Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy100000
Buy79810107
Hold911141182
Sell320000

Earnings and sales forecast

Next report: 27.10.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.10 (from $0.00 to $0.33). Last quarter: $2.51.

Sales

Next quarter’s sales estimate — $47.1B (from $45.6B to $49.2B). Last quarter: $53.6B.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Centene
  • CEO: Sarah McGinty London
  • Employees: 61,100
  • Centene Plaza, St. Louis, MO, 63105, US
  • www.centene.com

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Data from the stock’s TipRanks forecast page, read 66 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗